COVID-19 and systemic therapies in psoriasis: experience of a tertiary hospital in Madrid.

Fulgencio-Barbarin, Jon; Puerta-Peña, Mario; Ortiz-Romero, Pablo; García-Donoso, Carmen; Rivera-Diaz, Raquel

Fulgencio-Barbarin, Jon; Puerta-Peña, Mario; Ortiz-Romero, Pablo; García-Donoso, Carmen; Rivera-Diaz, Raquel.

Fulgencio-Barbarin J; 12 de Octubre University Hospital, Madrid, Spain.
Puerta-Peña M; 12 de Octubre University Hospital, Madrid, Spain.
Ortiz-Romero P; 12 de Octubre University Hospital, Madrid, Spain.
García-Donoso C; 12 de Octubre University Hospital, Madrid, Spain.
Rivera-Diaz R; 12 de Octubre University Hospital, Madrid, Spain.

Int J Dermatol ; 59(11): 1425-1426, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-744747

Subject(s)

COVID-19/complications; Psoriasis/complications; Psoriasis/drug therapy; Adult; Aged; Dermatologic Agents/therapeutic use; Female; Humans; Immunosuppressive Agents/therapeutic use; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Spain; Tertiary Care Centers

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Psoriasis / COVID-19 Type of study: Observational study Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Int J Dermatol Year: 2020 Document Type: Article Affiliation country: Ijd.15157

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google